Trial intelligence / Profile preview

Superficial Cervical Plexus Block for Maxillofacial Surgeries

NCT07236086Not yet recruiting

Sponsor
Assiut University
Start
Jan 2026
Primary completion
Jan 2027
Modality
Small Molecules
01

Overview

Randomised trial of bupivacaine in maxillofacial surgery (2 arms), sponsored by Assiut University. Primary endpoint: Time to first call for rescue analgesia at 24 hours. Planned start Jan 2026; status: not yet recruiting.

02

Drugs

bupivacaine
03

Conditions

maxillofacial surgery

Beyond the preview

Go deeper on NCT07236086.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07236086.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call